Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Miami, Florida 33126


Purpose:

This study compares the cardiac safety of inhaled indacaterol with that of placebo and oral moxifloxacin.


Criteria:

Inclusion Criteria: - Healthy, non-smoking - Body mass index (BMI) 18.5-32 kg/m2 - Body weight at least 50 kg Exclusion Criteria: - Recent/concurrent use of concomitant medications (except acetaminophen) - Recent participation in other clinical trials - Recent donation or loss of blood - History/presence of a range of medical conditions, including electrocardiographic (ECG) abnormalities, diabetes mellitus, hyperthyroidism and impaired renal function Other protocol-defined inclusion/exclusion criteria may apply


NCT ID:

NCT01263808


Primary Contact:

Study Director
Novartis Pharmaceuticals
Novartis Pharmaceuticals


Backup Contact:

N/A


Location Contact:

Miami, Florida 33126
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: August 31, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.